Heart & blood pressure · St. Louis area, MO
Heart and blood pressure studies in St. Louis area, MO
51 recruiting studies have a site in the St. Louis area. This page includes nearby cities such as Saint Louis, Chesterfield, Creve Coeur, Florissant.
51 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
Beijing Inno Medicine Co., Ltd.
- Location
- St Louis, MO
- Eligibility basics
- Ages 18–80
- Recruiting
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
Axon Therapies, Inc.
- Location
- St Louis, MO + 15 other US sites
- Eligibility basics
- Ages 40+
- Recruiting
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Medtronic Cardiovascular
- Location
- St Louis, MO + 68 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
BrioHealth Solutions, Inc.
- Location
- St Louis, MO + 46 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingPhase 2
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
Marea Therapeutics
- Location
- St Louis, MO + 6 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Inhibikase Therapeutics
- Location
- St Louis, MO + 14 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2/Phase 3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Merck Sharp & Dohme LLC
- Location
- St Louis, MO + 19 other US sites
- Eligibility basics
- Ages 1 mo–17
- RecruitingPhase 2
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Cytokinetics
- Location
- St Louis, MO + 23 other US sites
- Eligibility basics
- Ages 40–85
- Recruiting
Alleviant ALLAY-HF Study
Alleviant Medical, Inc.
- Location
- St Louis, MO + 42 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Eidos Therapeutics, a BridgeBio company
- Location
- Kansas City, MO + 39 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 4
Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
Eidos Therapeutics, a BridgeBio company
- Location
- St Louis, MO
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Novartis Pharmaceuticals
- Location
- St Louis, MO + 3 other US sites
- Eligibility basics
- Ages 2–11
- Recruiting
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Teleflex
- Location
- St Louis, MO + 9 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Anthos Therapeutics, Inc.
- Location
- Kansa City, MO + 131 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 2/Phase 3
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Kardigan, Inc.
- Location
- St Louis, MO + 46 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- St Louis, MO + 112 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 2
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Imbria Pharmaceuticals, Inc.
- Location
- St Louis, MO + 19 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Medtronic Terminate AF Study
Medtronic Cardiac Surgery
- Location
- St Louis, MO + 6 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Cardiac Dimensions, Inc.
- Location
- St Louis, MO + 50 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
XVIVO Perfusion
- Location
- St Louis, MO + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Kansas City, MO + 34 other US sites
- Eligibility basics
- Ages 12–18
- Recruiting
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
Endospan Ltd.
- Location
- St Louis, MO + 23 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
PARTNER 3 Trial - Aortic Valve-in-Valve
Edwards Lifesciences
- Location
- St Louis, MO + 28 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 1/Phase 2
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Sardocor Corp.
- Location
- St Louis, MO + 4 other US sites
- Eligibility basics
- Ages 18–80
Who these studies look for
Many require a diagnosis or specific lab values such as LDL cholesterol or blood pressure readings, and exclude recent heart events.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.